Europe and Israel Mobile Applications for Melanoma Detection Market is expected to surpass US$ 3.87 Mn in terms of value by the end of 2028

Cutaneous Melanoma (CM) is the most common type of melanoma. The predominant cause of melanoma is ultraviolet (UV) radiation, especially from the sun. Melanoma occurs on the outer layer of skin and is often directly visible and, thus, proper precaution and early detection of the same can help to cure this disease.

Market Statistics:

Europe and Israel mobile applications for melanoma detection market is expected to surpass US$ 3.87 Mn in terms of value by the end of 2028.

Europe and Israel Mobile Applications for Melanoma Detection Market: Drivers

Availability of affordable mobile applications for melanoma detection is expected to propel growth of the Europe and Israel mobile applications for melanoma detection market over the forecast period. For instance, Helfie.ai, an app developed by Australia-based entrepreneurs Nick Chang and Matthew Jones, enables users to take a photo of a mole or skin spot using their mobile. The app reportedly checks for skin cancer within minutes for just US$ 3.

Europe and Israel Mobile Applications for Melanoma Detection Market: Opportunities

Integration of mobile applications for melanoma detection with patient data management solutions is expected to offer lucrative growth opportunities for players in the Europe and Israel mobile applications for melanoma detection market. An electronic health record (EHR) is a digital record of patients’ medical history. Such historical information is crucial for healthcare personnel to carry out diagnosis and treatment. EMRs offer various benefits such as patient identification, tracking of medical data over time, monitoring health parameters such as blood pressure or skin status, and improving the overall quality of healthcare practice.

Europe and Israel Mobile Applications for Melanoma Detection Market: Recent Developments  

On July 21, 2021, Denmark based company Skin checking app (Digital health app) Miiskin has launched a new mole sizing feature which allows patients to check if their moles have changed size via augmented reality technology.

On May 21, 2021, Google has announced to launch a new AI App Derm Assist to diagnose skin conditions. This app has been armed with a C.E. mark as a Class I Medical Device in the E.U., with plans for an ongoing pilot study and launch there later this year

In October 2019, MetaOptima Technology Inc. has participated in the International Certificate of Dermatoscopy and Skin Cancer Medicine symposium held at London to showcase its products and conduct training

Europe and Israel Mobile Applications for Melanoma Detection Market: Restraints

Sluggish internet connection in some European countries is expected to hinder growth of the Europe and Israel mobile applications for melanoma detection market. For instance, use of copper cables in Germany offers internet that is not capable to go faster than 250 megabits per second and the average reality is about 50 megabits per second.

To know the latest trends and insights prevalent in the Europe and Israel Mobile Applications for Melanoma Detection Market, click the link below:

https://www.coherentmarketinsights.com/market-insight/europe-and-israel-mobile-applications-for-melanoma-detection-market-4642

Europe and Israel Mobile Applications for Melanoma Detection Market - Impact of Coronavirus (Covid-19) Pandemic

The COVID-19 pandemic has affected the diagnosis and management of many diseases including melanoma. In Israel, from 3 January 2020 to 5:29pm CEST, 8 September 2021, there have been 1,117,596 confirmed cases of COVID-19 with 7,205 deaths, reported to WHO. As of 3 September 2021, a total of 14,101,310 vaccine doses have been administered. Efforts to curb the transmission of COVID-19 has resulted in widespread disruptions to medical practices, including the provision of routine dermatologic care. Such scenario is expected to boost adoption of mobile applications for melanoma detection.   

Key Takeaways:

• Europe and Israel mobile applications for melanoma detection market was valued at US$ 0.79 Mn in 2020 and is forecast to reach a value of US$ 3.87 Mn by 2028 at a CAGR of 19.6% between 2021 and 2028.
• The Mole Tracking and Reminder Applications segment was valued US$ 0.22 Mn in 2020 and is expected to witness a CAGR of 19.3% over the forecast period.

Market Trends

The Europe and Israel mobile applications for melanoma detection market is witnessing approval and launch of artificial intelligence imaging system for detecting skin cancer. For instance, in January 2020, 3Derm Systems received the U.S. Food and Drug Administration breakthrough device designations for its 3DermSpot autonomous artificial intelligence imaging system for detecting skin cancer.

Major organizations are focused on funding projects for development of novel solutions for various cancers. For instance, the EU-funded ESMART project developed Advanced Symptom Management System (ASyMS), a mobile-phone-based remote monitoring system, monitors cancer patients' symptoms and treatment side effects, helping to improve management of the disease.

Europe and Israel Mobile Applications for Melanoma Detection Market: Competitive Landscape  

Major players operating in the Europe and Israel  mobile applications for melanoma detection market include, SkinVision, DermaCompare, Dermatology Planet, DermLink.MD, Doctor Mole, FotoSkin, iDoc24, iSkin, LoveMySkin, and Melanoma Calculator.

Europe and Israel Mobile Applications for Melanoma Detection Market: Key Developments

September 2019: SkinVision was selected to join the DigitalHealth.London Accelerator, a programme aiming to speed up the adoption of technology in London’s NHS